Sexual dysfunction in schizophrenia: focus on recent evidence

	Tweet

Abstract
Background
Antipsychotic medications are known to be commonly associated with sexual dysfunction. Sexual dysfunction is estimated to affect 30–80% of patients with schizophrenia and is a major cause of poor quality of life. However, few comparative studies on the sexual dysfunction effects associated with antipsychotic medication have been published and the effects of the newer atypical antipsychotics have been largely unexamined.

Objective
This review aims to examine the latest evidence regarding the sexual function effects of different antipsychotic medications, particularly the newer prolactin-sparing drugs, quetiapine and aripiprazole, in patients with schizophrenia and schizoaffective psychosis.

Methods
A literature search was conducted within PubMed/MEDLINE using the terms risperidone, haloperidol, clozapine, olanzapine, ziprasidone, quetiapine, aripiprazole; sexual dysfunction; schizophrenia. The results were limited to studies published since 2002.

Results
Recently published studies show that the relative impact of antipsychotics on sexual dysfunction can be summarised as risperidone > typical antipsychotics (haloperidol) > olanzapine > quetiapine > aripiprazole.

Conclusions
The availability of prolactin-sparing antipsychotics should enable psychiatrists to consider and manage proactively the sexual function consequences of pharmacological intervention, thereby improving sexual side effects, which may lead to improved treatment adherence and psychiatric outcome in patients with schizophrenia. Copyright © 2008 John Wiley & Sons, Ltd.

###
Martin Baggaley

Article first published online: 13 MAR 2008
DOI: 10.1002/hup.924
Get PDF (97K)

RELATED STORIES:
Schizophrenia: A Review   Patients with Schizophrenia More Likely to Have Medical Complications   Schizophrenia Linked to Early Death   Theory of mind in schizophrenia   Brain memory finding may help schizophrenia research   Searching for causes of neural disconnection in schizophrenia   Gender differences in schizophrenia   Gifts of the MAGI in schizophrenia and bipolar disorder   How to treat nicotine dependence in smokers with schizophrenia   Brain development goes off track as vulnerable individuals develop schizophrenia   Prenatal flu exposure tied to schizophrenia risk   ‘Awareness, timely treatment can help cure schizophrenia’   New “Schizophrenia Gene” Prompts Researchers to Test Potential Drug Target   Discovery of new gene mutation in schizophrenia offers a new target for drug therapies   CAMH study suggests increased risk of schizophrenia in heavy methamphetamine users

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]